CTOs on the Move

Moore Norman Technology Center

www.mntechnology.com

 
Moore Norman Technology Center is a Norman, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Deerwalk

Deerwalk Incorporated is a revolutionary Population Health Management and Healthcare Analytics Software Company, which offers customers a range of quality products and services to meet their healthcare needs. Deerwalk`s understanding and experience in the Healthcare Analytics industry is unparalleled, offering Big Data and NoSQL products and services to Third Party Administrators, Brokers and Consultants, Employers and Providers, Health Plans, Accountable Care Organizations, Disease / Care Managers, and Health Coaches.

APER Solutions

APER Solutions is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Focus Health

Focus Health is a Kearney, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

South Carolina Heart Center

South Carolina Heart Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Columbia, SC. To find more information about South Carolina Heart Center, please visit www.scheart.com

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.